Back to top

Denali Monetizes FDA Voucher to Advance CNS Pipeline

Denali Therapeutics ( ($DNLI) ) has provided an announcement. On June 12, 2026, Denali Therapeutics entered into an asset purchase agreement to sel...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Denali Therapeutics Inc. (DNLI)